What Is Your Choice for Androgen Deprivation Therapy in Metastatic Prostate Carcinoma: Surgical or Medical?

• DOI: 10.5152/tju.2022.22076
• Publication Date: 2022-07-28T12:19:25Z
• Authors: Huseyin Salih Semiz; Erdem Kisa; ; Eda Caliskan Yild...; ; Elif Atag; ; Mehmet Emin Arayici; ; Talha Muezzinoglu; ; Aziz Karaoglu
• Keywords: Orchiectomy; Metastatic carcinoma

At the time of diagnosis, approximately 16.5% prostate cancer patients are metastatic. The main framework metastatic treatment is androgen deprivation therapy, which performed surgically or medically. aim this study to evaluate attitudes medical oncologists and urologists about orchiectomy as therapy.A total 387 physicians working in Departments Urology (n=217) Medical Oncology (n=170) were included descriptive study. Data collected through an electronic survey.Only 7.5% participants indicated that they offered surgical castration their patients. Urologists preferred more than for castration-sensitive carcinoma (P=.003). reasons why less it invasive procedure, has risk morbidity mortality, high cost hospitalization, may cause deterioration patient's body image (P < .05).This showed likely perform therapy. Although most important reason patient preference, biased presentation options patients, lack knowledge orchiectomy, effect pharmaceutical industry should also be kept mind.